α-synuclein生物标记物的现状和对α-synuclein PET标记物的需求

Sara E Berman1, Andrew D Siderowf1

  • 1Parkinson's Disease and Movement Disorders Center, Department of Neurology, Pennsylvania Hospital, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Cells
|August 27, 2025
PubMed
概括

开发α-同核素PET标记剂对于诊断同核素病变至关重要. 目前的生物标志物有局限性,突出显示需要体内成像来追踪疾病进展和治疗反应.